Take home messages Prognostic and predictive biomarkers should be biologically meaningful, robust, reproducible, widely available and affordable to serve as meaningful companion diagnostics. Multimodality profiles will be needed for successful biomarker-driven introduction of personalized and targeted treatments; single markers will not suffice.
机构:
Mayo Clin Arizona, Div Internal Med, Div Hematol Med Oncol, Phoenix, AZ USAMayo Clin Arizona, Div Internal Med, Div Hematol Med Oncol, Phoenix, AZ USA
Rosenthal, Allison
Rimsza, Lisa
论文数: 0引用数: 0
h-index: 0
机构:
Mayo Clin Arizona, Dept Lab Med & Pathol, Div Hematopathol, Phoenix, AZ USAMayo Clin Arizona, Div Internal Med, Div Hematol Med Oncol, Phoenix, AZ USA
机构:
Univ Sydney, Northern Blood Res Ctr, Kolling Inst Med Res, Sydney, NSW 2006, AustraliaUniv Sydney, Northern Blood Res Ctr, Kolling Inst Med Res, Sydney, NSW 2006, Australia
Gifford, Grace K.
Gill, Anthony J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sydney, Canc Diag & Pathol Grp, Kolling Inst Med Res, Sydney, NSW 2006, Australia
Royal N Shore Hosp, Dept Anat Pathol, Sydney, NSW, AustraliaUniv Sydney, Northern Blood Res Ctr, Kolling Inst Med Res, Sydney, NSW 2006, Australia
Gill, Anthony J.
Stevenson, William S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sydney, Northern Blood Res Ctr, Kolling Inst Med Res, Sydney, NSW 2006, Australia
Royal N Shore Hosp, Dept Haematol & Transfus Med, Sydney, NSW, AustraliaUniv Sydney, Northern Blood Res Ctr, Kolling Inst Med Res, Sydney, NSW 2006, Australia